CriticalPoint(TM) Launches Seven New Virtual Compounder(TM) Traini...(SHP members Eric S. Kastango Jim Wagner ...),Health
Navigation Links
CriticalPoint(TM) Launches Seven New Virtual Compounder(TM) Training Modules
Date:8/31/2009
SHP members Eric S. Kastango, Jim Wagner, Patricia Kienle, Luci Power, Holly Simmons and Kate Douglass among others; CriticalPoint is a comprehensive solution for understanding best practice in sterile compounding, managing training requirements, evaluating personnel competency and documenting personnel certification. Not only is the training extensive, but the software incorporates a Learning Management System (LMS) that allows pharmacy managers to track all pharmacy training conveniently. Together, the LMS capabilities and the expert written training provide pharmacies with a one-stop solution to USP < 797 > training compliance.
CriticalPoint is a product of CriticalPoint, LLC. Baxa Corporation markets the CriticalPoint compliance training modules as part of its Productivity and Compliance Tools (PACT) product line, which includes the Skills Training, Academics and Resources (STAR) Center classroom-based training for USP < 797 > compliance and aseptic compounding. Through the STAR Center's hands-on training programming and the CriticalPoint Web-based training modules, Baxa provides a complete solution for pharmacy compliance training in sterile compounding. For a demonstration of The Virtual Compounder programs, or for more information on CriticalPoint training, visit www.baxa.com/criticalpoint.
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications. Key products include the PadLock(R) Set Saver, Rapid-Fill(TM) Automated Syringe Fillers, ExactaMed(R) Oral Dispensers, MicroFuse(R) Syringe Infusers, Repeater(TM) Pharmacy Pumps, the IntelliFlow(TM) System and ExactaMi
'/>"/>
| SOURCE Baxa Corporation Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. CriticalPoint(TM) Training Rated Excellent in Customer Satisfaction
2. Connectyx Launches MedFlash Electronic Personal Health Record with Harris Teeter Supermarket Chain
3. Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets
4. BioSpace Launches the 2009-2010 Biotech Bay Hotbed Campaign
5. DoctorSolve.Com Relaunches, Offers Greater Customer Interaction
6. MPA Media Launches New Chiropractic Publication, Dynamic Chiropractic PracticeINSIGHTS
7. LaserSculpt, Inc. Launches LaserSculpt Infomercial
8. Weight Watchers(R) Launches New Community on WeightWatchers.com
9. Upsher-Smith Launches New Website for Divigel(R), a Bioidentical and FDA-Approved Hormone Therapy for Moderate to Severe Hot Flashes, Including Night Sweats, Associated with Menopause
10. Anesthetix Launches OPTIMETRIX(TM) Perioperative Quality Management Tool
11. Home Delivery Medical Launches New Division For Sleep Centers
Post Your Comments:
(Date:11/26/2009)...of the Live Life Again Center, a practice offering...ing number of physicians who are taking advantage...h individuals who are interested in surgical weigh...is utilizing Facebook to share before-and-after ph...ommunity. , Dallas, TX (V...
(Date:11/25/2009).../--TheBartleHallConventionCenterwilltemporarilybec...ansasCityhoststhelatestinaseriesofmassivefreeclini...sthepotentialtobethebiggestoneyet,becauseitwillext...nsteadofoveraweekend,"SheriWood,executivedirectoro...ionalAssociationofFreeClinics(NAFC). ,, Atprevi...
(Date:11/25/2009)...re-USNewswire/--AnarticlebyJanetWoodcock,M.D.,dire...itled"ADifficultBalance-PainManagement,DrugSafety,...landJournalofMedicine. ,, (Logo: http://www.new...hearticle,WoodcockdiscussesFDAeffortstostrikeabala...ndmanagingtherisksposedbyvariousanalgesics.Asexamp...
(Date:11/25/2009)...tatistically significant survival benefit from adj...ptor (ER)-positive tumors had high levels of phosp...18-P), according to a brief communication publishe...al Cancer Institute . , Approximately 50% of bre...ical studies have shown that ER-alpha S118-P is re...
(Date:11/25/2009)... treatment clinics to resume Monday, Nov. 30 , ...5, 2009 -- Centegra Health System is continuing to...at four Centegra Primary Care (CPC) vaccination cl...d. The clinics are at CPC sites in Huntley, Woodst...follows: , From 4:30 to 7:30 p.m. Tu...
Breaking Medicine News(10 mins):Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4[1] Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients[1] Kansas City Prepares for Largest Free Health Clinic[1] FDA's Woodcock Discusses Pain Management and Drug Safety in Nov. 26, 2009 Issue of The New England Journal of Medicine[2] News brief: Estrogen receptor-alpha, breast cancer patients and tamoxifen response[0] Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1
...echniques of soft condensed matter physics, a rese...finely tuned balance of attractions between protei... even a small change in this balance can cause pro...gregation diseases (such as Alzheimers disease), a...
...007) New research published in the November issue...s shows that urban colorectal and lung cancer pati... patients do. This finding is contrary to the com...nts presenting with metastatic cancer is alarming,...
... 9 Hooper Holmes,Inc. (Amex: HH ), a leading pro...unced financial results for the third quarter ende...were $56.3 million compared to $60.6,million in th... loss of $42.1 million or $(0.63) per share in the...
... Pharmaceutical product teams,have the power to m...lem is,launch teams often lack the right structure...fore only produce a sub-optimal launch. In fact, ...ialization. According to a study by pharmaceutical...
...y Distributing over 12 Million Narcotic Pain,Pills...ney Matt M. Dummermuth announced today that six me...istribute controlled substances through an,Interne... Rapids. The indictment also seeks forfeiture of m...
...now be mapped less to mathematical standards and m...y by researchers at Harvard and Johns Hopkins Univ...onal Biology on November 9, 2007, provides a new p...cancer has long been based on streamlined models w...
Other Medicine News:Health News:Physics provides new insights on cataract formation 2Health News:Study reveals differences in cancer stage presentation between rural and urban patients 2Health News:Hooper Holmes Announces Third Quarter 2007 Results 2Health News:Hooper Holmes Announces Third Quarter 2007 Results 3Health News:Hooper Holmes Announces Third Quarter 2007 Results 4Health News:Hooper Holmes Announces Third Quarter 2007 Results 5Health News:Hooper Holmes Announces Third Quarter 2007 Results 6Health News:Hooper Holmes Announces Third Quarter 2007 Results 7Health News:Pharmaceutical Product Commercialization: Enabling Teams to Excel 2Health News:Pharmaceutical Product Commercialization: Enabling Teams to Excel 3Health News:$40 Million Forfeiture Sought in Nation-Wide Internet Pharmacy Case 2Physics provides new insights on cataract formationStudy reveals differences in cancer stage presentation between rural and urban patientsHooper Holmes Announces Third Quarter 2007 ResultsPharmaceutical Product Commercialization: Enabling Teams to Excel$40 Million Forfeiture Sought in Nation-Wide Internet Pharmacy CaseA new mathematical formula for cancer progression
(Date:11/25/2009)...wswire/-- ChemoCentryx,Inc.,announcedtodaythatPha...rospectiveRandomizedOralTherapyEvaluationinCrohn,s...withmoderate-to-severeCrohn,sdiseasedemonstratedcl...rofile.Thestudydemonstratedevidenceofclinicaleffic...ointdecreaseintheCrohn,sDiseaseActivityIndex(CDAI)...
(Date:11/24/2009)...-FirstCall/--Endologix,Inc.(Nasdaq: ELGX ),develop...announcedtodaythatithasfiledamotiontostay,ordiscon...broughtagainstitinOctober2009byCook,Inc.Themotionw...s,Indiana. ,, Endologixhasrequestedthatthestayr...kOffice(USPTO)conductsproceedingstore-examinethetw...
(Date:11/24/2009)...tCall/--AnadysPharmaceuticals,Inc.(Nasdaq: ANDS )a...JaffrayHealthcareConferenceonTuesday,December1,200...ldatTheNewYorkPalaceHotel.SteveWorland,Ph.D.,Presi...overviewofAnadysanditsclinicaldevelopmentprograms,...lbesimultaneouslywebcastandcanbeaccessedontheInves...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Patient Centered Primary Care Collaborative Stakeholders Come to Washington DC for July Working Meeting 49072 1Patient Centered Primary Care Collaborative Stakeholders Come to Washington DC for July Working Meeting 49072 2Patient Centered Primary Care Collaborative Stakeholders Come to Washington DC for July Working Meeting 49072 3Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 1Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 2Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 3Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 4Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 5Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 6Government of Canada supports research to help address medical isotope shortage 49067 1...tandard Regimen of Androgen Deprivation and, Chemo...by More than Half - - Data Further Confirm Bavit... Combination Regimens for Cancer Therapy -, ATL...aceuticals, Inc. (Nasdaq: PPHM ), a clinical stag...noclonal antibodies for the,treatment of cancer an...
...tandard Regimen of Androgen Deprivation and, Chemo...by More than Half - - Data Further Confirm Bavit... Combination Regimens for Cancer Therapy -, ATL...aceuticals, Inc. (Nasdaq: PPHM ), a clinical stag...noclonal antibodies for the,treatment of cancer an...
Other Medicine Technology:Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 2Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 3Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 4Peregrine Reports Data Showing Bavituximab's Potential to Shrink Prostate Tumors 2Peregrine Reports Data Showing Bavituximab's Potential to Shrink Prostate Tumors 3Peregrine Reports Data Showing Bavituximab's Potential to Shrink Prostate Tumors 4...ears -- and works! Baby Gender Mentor Home DNA Gen...nology to attain the earliest gender detection wit...cy. The technique traces the amount of Y chromosom...Here's how it works: Your baby releases its DNA in...
...roducts, ,Westmed designs, manufacturers and mark... and Respiratory professionals. Our mission is to ...linician's ability to deliver quality medical care..., ,Our web site is designed with our customers in...
...mbrane glycoprotein associated with tyrosine kinas...ancer show an amplification and/or over-expression...on of Herceptin® as a targeted therapy for bre...reast carcinoma has become very important in patie...
...roducts, ,Westmed designs, manufacturers and mark... and Respiratory professionals. Our mission is to ...linician's ability to deliver quality medical care..., ,Our web site is designed with our customers in...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |